3 studies found for:    18F-FMAU
Show Display Options
Rank Status Study
1 Recruiting 18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
Condition: Malignant Neoplasm
Interventions: Radiation: fluorine F 18 d-FMAU;   Procedure: positron emission tomography;   Procedure: computed tomography
2 Recruiting PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
Conditions: HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Other: laboratory biomarker analysis;   Other: pharmacological study;   Other: questionnaire administration;   Radiation: fluorine F 18-clevudine;   Procedure: positron emission tomography/computed tomography
3 Recruiting Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabozantinib-s-malate;   Radiation: fluorine F 18 d-FMAU;   Procedure: positron emission tomography;   Other: pharmacological study;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years